Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy

Transarterial chemoembolization (TACE) is the first-line treatment for unresectable intermediate-stage hepatocellular carcinoma (HCC). It is of high clinical significance to explore the synergistic effect of TACE with antiangiogenic inhibitors and the molecular mechanisms involved. This study determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jing, Feng, Ji, Wu, Yong, Dai, Hui-Qi, Zhu, Guang-Zhi, Chen, Pan-Hong, Wang, Li-Ming, Lu, Guang, Liao, Xi-Wen, Lu, Pei-Zhi, Su, Wen-Jing, Hooi, Shing Chuan, Ye, Xin-Pin, Shen, Han-Ming, Peng, Tao, Lu, Guo-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723179/
https://www.ncbi.nlm.nih.gov/pubmed/36385558
http://dx.doi.org/10.1038/s12276-022-00878-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723179/
https://www.ncbi.nlm.nih.gov/pubmed/36385558
http://dx.doi.org/10.1038/s12276-022-00878-x

Ejemplares similares